NL7906232A - Vaste, uit een laminaat opgebouwde farmaceutische preparaten. - Google Patents

Vaste, uit een laminaat opgebouwde farmaceutische preparaten. Download PDF

Info

Publication number: NL7906232A
Authority: NL; Netherlands
Prior art keywords: laminate; sheets; drug; layers; paper
Prior art date: 1978-08-21

Application number

NL7906232A

Other languages

English (en)

Dutch (nl)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-08-21

Filing date

1979-08-15

Publication date

1980-02-25

1979-08-15 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1980-02-25 Publication of NL7906232A publication Critical patent/NL7906232A/nl

Links

239000007787 solid Substances 0.000 title claims description 6
239000000825 pharmaceutical preparation Substances 0.000 title description 3
239000003814 drug Substances 0.000 claims description 30
239000002552 dosage form Substances 0.000 claims description 28
239000000203 mixture Substances 0.000 claims description 26
229940079593 drug Drugs 0.000 claims description 25
229920002785 Croscarmellose sodium Polymers 0.000 claims description 21
239000000835 fiber Substances 0.000 claims description 11
239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
239000000725 suspension Substances 0.000 claims description 5
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
230000001476 alcoholic effect Effects 0.000 claims description 3
239000010410 layer Substances 0.000 description 41
238000000034 method Methods 0.000 description 14
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
239000000945 filler Substances 0.000 description 7
239000011247 coating layer Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
239000000758 substrate Substances 0.000 description 6
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 5
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
239000001863 hydroxypropyl cellulose Substances 0.000 description 5
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 5
238000007789 sealing Methods 0.000 description 5
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
210000002784 stomach Anatomy 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 4
239000007884 disintegrant Substances 0.000 description 4
239000012528 membrane Substances 0.000 description 4
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
229940105329 carboxymethylcellulose Drugs 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
235000010980 cellulose Nutrition 0.000 description 3
230000032798 delamination Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
239000003607 modifier Substances 0.000 description 3
229920003043 Cellulose fiber Polymers 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 2
229960004782 chlordiazepoxide Drugs 0.000 description 2
230000001427 coherent effect Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000003475 lamination Methods 0.000 description 2
-1 pectin Chemical class 0.000 description 2
239000004014 plasticizer Substances 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000002904 solvent Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
238000005406 washing Methods 0.000 description 2
241000220479 Acacia Species 0.000 description 1
229920002799 BoPET Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
108010082495 Dietary Plant Proteins Proteins 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
241001082241 Lythrum hyssopifolia Species 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
239000005041 Mylar™ Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
229920002522 Wood fibre Polymers 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000003490 calendering Methods 0.000 description 1
238000005266 casting Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
239000011121 hardwood Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
238000010030 laminating Methods 0.000 description 1
238000011068 loading method Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000003801 milling Methods 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
239000001814 pectin Substances 0.000 description 1
235000010987 pectin Nutrition 0.000 description 1
229920001277 pectin Polymers 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229940068965 polysorbates Drugs 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
235000019422 polyvinyl alcohol Nutrition 0.000 description 1
235000003441 saturated fatty acids Nutrition 0.000 description 1
150000004671 saturated fatty acids Chemical class 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000000565 sealant Substances 0.000 description 1
239000011122 softwood Substances 0.000 description 1
239000007892 solid unit dosage form Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
238000004260 weight control Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31971—Of carbohydrate
- Y10T428/31975—Of cellulosic next to another carbohydrate
- Y10T428/31978—Cellulosic next to another cellulosic

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Laminated Bodies (AREA)

NL7906232A 1978-08-21 1979-08-15 Vaste, uit een laminaat opgebouwde farmaceutische preparaten. NL7906232A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US93527478		1978-08-21
US05/935,274 US4180558A (en)	1978-08-21	1978-08-21	Unit dosage forms

Publications (1)

Publication Number	Publication Date
NL7906232A true NL7906232A (nl)	1980-02-25

Family

ID=25466839

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL7906232A NL7906232A (nl)	1978-08-21	1979-08-15	Vaste, uit een laminaat opgebouwde farmaceutische preparaten.

Country Status (17)

Country	Link
US (1)	US4180558A (it)
JP (1)	JPS6038366B2 (it)
AT (1)	AT371708B (it)
AU (1)	AU521053B2 (it)
BE (1)	BE878306R (it)
CA (1)	CA1110168A (it)
DE (1)	DE2932615C2 (it)
DK (1)	DK154186C (it)
FR (1)	FR2433942A2 (it)
GB (1)	GB2028135B (it)
IE (1)	IE48678B1 (it)
IT (1)	IT1123531B (it)
LU (1)	LU81614A1 (it)
NL (1)	NL7906232A (it)
PH (1)	PH15463A (it)
SE (1)	SE440726B (it)
ZA (1)	ZA794240B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0010987B1 (en) *	1978-11-07	1983-10-05	Beecham Group Plc	Device for oral administration to a ruminant animal
JPS5770816A (en) *	1980-10-17	1982-05-01	Ono Pharmaceut Co Ltd	Multilayered film preparation of prostagladin of prolonged action
US4381780A (en) *	1981-01-19	1983-05-03	Research Corporation	Sustained release delivery system
JPS58134019A (ja) *	1982-02-05	1983-08-10	Ono Pharmaceut Co Ltd	プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
JPS5948409A (ja) *	1982-09-10	1984-03-19	Teikoku Seiyaku Kk	矯正的歯牙移動促進剤
JPS62186953U (it) *	1986-05-19	1987-11-27
US5451673A (en) *	1993-04-23	1995-09-19	The United States Of America As Represented By The Secretary Of Agriculture	Films fabricated from mixtures of pectin and starch
DE19806966A1 (de)	1998-02-19	1999-09-09	Lohmann Therapie Syst Lts	Verfahren und Vorrichtung zum Einbringen einer Vielzahl vereinzelter folienförmiger Darreichungsformen in einen Spender unter Bildung eines viellagigen Stapels
BR112013000101A2 (pt)	2010-07-02	2016-05-17	Procter & Gamble	filamentos compreendendo mantas de não tecido com agente ativo e métodos de fabricação dos mesmos
RU2535040C2 (ru)	2010-07-02	2014-12-10	Дзе Проктер Энд Гэмбл Компани	Способы доставки медицинского активного агента путем введения индивидуальных медицинских изделий, содержащих филамент
PL2588288T3 (pl)	2010-07-02	2016-04-29	Procter & Gamble	Proces wytwarzania powłok z siatek włókninowych
BR112013000104A2 (pt)	2010-07-02	2016-05-17	Procter & Gamble	produto detergente
EP2588655B1 (en)	2010-07-02	2017-11-15	The Procter and Gamble Company	Method for delivering an active agent
EP2578088A1 (en)	2011-10-06	2013-04-10	Nestec S.A.	Edible web comprising microorganisms
EP3573593B1 (en)	2017-01-27	2023-08-30	The Procter & Gamble Company	Compositions in the form of dissolvable solid structures
KR20200086739A (ko)	2018-01-26	2020-07-17	더 프록터 앤드 갬블 캄파니	효소를 포함하는 수용성 단위 용량 물품
JP7110356B2 (ja)	2018-01-26	2022-08-01	ザプロクターアンドギャンブルカンパニー	香料を含む水溶性単位用量物品
US11053466B2 (en)	2018-01-26	2021-07-06	The Procter & Gamble Company	Water-soluble unit dose articles comprising perfume
EP3743503B1 (en)	2018-01-26	2026-04-29	The Procter & Gamble Company	Process for making water-soluble articles
WO2019168829A1 (en)	2018-02-27	2019-09-06	The Procter & Gamble Company	A consumer product comprising a flat package containing unit dose articles
US10982176B2 (en)	2018-07-27	2021-04-20	The Procter & Gamble Company	Process of laundering fabrics using a water-soluble unit dose article
US12234431B2 (en)	2018-10-03	2025-02-25	The Procter & Gamble Company	Water-soluble unit dose articles comprising water-soluble fibrous structures and particles
CN113748195B (zh)	2019-01-28	2024-01-19	宝洁公司	可回收利用的、可再生的或可生物降解的包装
EP3942008A1 (en)	2019-03-19	2022-01-26	The Procter & Gamble Company	Process of reducing malodors on fabrics
EP3712237A1 (en)	2019-03-19	2020-09-23	The Procter & Gamble Company	Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7381613B2 (ja)	2019-06-28	2023-11-15	ザプロクターアンドギャンブルカンパニー	アニオン性界面活性剤を含有する溶解性固体繊維性物品
JP7506249B2 (ja)	2020-07-31	2024-06-25	ザプロクターアンドギャンブルカンパニー	ヘアケア用プリル含有水溶性繊維パウチ
JP7605842B2 (ja)	2020-08-19	2024-12-24	ザプロクターアンドギャンブルカンパニー	直接添加マイクロカプセルを含有する可撓性多孔質溶解性固体シート物品及びそれを作製するための方法
WO2023034763A1 (en)	2021-08-30	2023-03-09	The Procter & Gamble Company	Dissolvable solid structure comprising first and second polymeric structurants
CN118541127A (zh)	2021-12-17	2024-08-23	宝洁公司	含有盐的可溶性固体纤维洗发剂制品
EP4489719A1 (en)	2022-03-10	2025-01-15	The Procter & Gamble Company	Dissolvable solid structure having first and second layers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4029758A (en) *	1975-12-15	1977-06-14	Hoffmann-La Roche Inc.	Preparation of pharmaceutical unit dosage forms

1978
- 1978-08-21 US US05/935,274 patent/US4180558A/en not_active Expired - Lifetime
1979
- 1979-08-10 DE DE2932615A patent/DE2932615C2/de not_active Expired
- 1979-08-14 ZA ZA00794240A patent/ZA794240B/xx unknown
- 1979-08-14 AU AU49925/79A patent/AU521053B2/en not_active Expired
- 1979-08-15 NL NL7906232A patent/NL7906232A/nl not_active Application Discontinuation
- 1979-08-17 PH PH22921A patent/PH15463A/en unknown
- 1979-08-17 JP JP54104122A patent/JPS6038366B2/ja not_active Expired
- 1979-08-20 AT AT560779A patent/AT371708B/de not_active IP Right Cessation
- 1979-08-20 FR FR7920955A patent/FR2433942A2/fr active Granted
- 1979-08-20 SE SE7906942A patent/SE440726B/sv not_active IP Right Cessation
- 1979-08-20 IT IT2517079A patent/IT1123531B/it active
- 1979-08-20 LU LU81614A patent/LU81614A1/de unknown
- 1979-08-20 IE IE1590/79A patent/IE48678B1/en unknown
- 1979-08-20 GB GB7928890A patent/GB2028135B/en not_active Expired
- 1979-08-20 BE BE0/196780A patent/BE878306R/fr not_active IP Right Cessation
- 1979-08-20 DK DK348079A patent/DK154186C/da active
- 1979-08-20 CA CA334,136A patent/CA1110168A/en not_active Expired

Also Published As

Publication number	Publication date
AU521053B2 (en)	1982-03-11
LU81614A1 (de)	1980-09-24
PH15463A (en)	1983-01-24
CA1110168A (en)	1981-10-06
JPS6038366B2 (ja)	1985-08-31
JPS5528986A (en)	1980-02-29
GB2028135A (en)	1980-03-05
FR2433942A2 (fr)	1980-03-21
US4180558A (en)	1979-12-25
SE440726B (sv)	1985-08-19
BE878306R (fr)	1980-02-20
SE7906942L (sv)	1980-02-22
ATA560779A (de)	1982-12-15
DE2932615A1 (de)	1980-03-06
AT371708B (de)	1983-07-25
DK154186B (da)	1988-10-24
ZA794240B (en)	1980-08-27
IE48678B1 (en)	1985-04-17
AU4992579A (en)	1980-02-28
DK348079A (da)	1980-02-22
DK154186C (da)	1989-03-13
FR2433942B2 (it)	1983-09-09
GB2028135B (en)	1983-03-30
IE791590L (en)	1980-02-21
DE2932615C2 (de)	1985-06-05
IT7925170A0 (it)	1979-08-20
IT1123531B (it)	1986-04-30

Legal Events

Date	Code	Title	Description
1980-03-25	BA	A request for search or an international-type search has been filed
1982-02-01	BB	A search report has been drawn up
1984-12-03	BC	A request for examination has been filed
1985-01-01	A85	Still pending on 85-01-01
1989-12-18	CNR	Transfer of rights (patent application after its laying open for public inspection)	Free format text: HOFFMANN-LA ROCHE AG. F. -
1991-04-02	BV	The patent application has lapsed

Publication	Publication Date	Title
NL7906232A (nl)	1980-02-25	Vaste, uit een laminaat opgebouwde farmaceutische preparaten.
DE69636223T2 (de)	2007-04-19	Formulierung mit gesteuerter Freisetzung für wasserlösliche Arzneistoffe, in der eine Auslauföffnung in Situ gebildet wird
EP0936905B1 (de)	2003-08-27	Sofortige benetzbarkeit aufweisende(r) wasserlöslicher film oder wasserlösliche schicht zur oralen applikation
NL194636C (nl)	2002-10-04	Werkwijze voor het opnieuw samenstellen van tabak alsmede daarmee verkregen product.
CA1275046A (en)	1990-10-09	Method of preparing an application and dosage form for drugs, reagents and other active agents
EP0259749B1 (de)	1991-08-14	Darreichungs- und Dosierungsform für Arzneimittelwirkstoffe, Reagentien oder dergleichen sowie Verfahren zu deren Herstellung
EP0808158B1 (de)	2000-03-08	Arzneiform zur abgabe von wirkstoffen an wunden
EP0872234B1 (de)	2005-03-16	Laminare Arzneiform
EP0355470B1 (de)	1992-10-14	Retardierte Arzneiform und Verfahren zu ihrer Herstellung
CH636276A5 (de)	1983-05-31	Durch osmose betaetigbare abgabevorrichtung.
EP0250374B1 (en)	1991-05-02	Therapeutic system for controlled release of drugs
EP0835102A1 (en)	1998-04-15	Controlled release formulation having a preformed passageway
EP2129275A1 (de)	2009-12-09	Biologisch abbaubares mehrschichtsystem
DE19652188A1 (de)	1998-06-18	Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung
WO1998026763A1 (de)	1998-06-25	Wirkstoffträger für die freisetzung von apomorphin in der mundhöhle
EP2863896B1 (de)	2016-09-14	Arzneiform zur freisetzung von wirkstoffen
US3033754A (en)	1962-05-08	Tablets containing hydrazine derivatives
DE69904465T2 (de)	2003-10-02	Therapie von depressionen
EP0946150B1 (de)	2002-03-06	Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff
WO2011072474A1 (zh)	2011-06-23	双环醇双层渗透泵控释片剂及其制备方法
US20080227168A1 (en)	2008-09-18	Methods and materials for extra and intracellular delivery of carbon nanotubes
DE2930321A1 (de)	1980-04-10	Verfahren zur herstellung eines neuen pharmazeutischen hilfsstoffes und daraus hergestellte feste arzneiformen
WO2000025759A1 (de)	2000-05-11	Oral applizierbare, mit flüssigkeit spontan zerfallende therapeutische darreichungsform und verfahren zu ihrer herstellung
EP4482663A1 (de)	2025-01-01	Verwendung von mindestens einlagiger zellstoffwatte zur herstellung von umgeformten produkten
EP1558209A1 (de)	2005-08-03	Transmucosale pharmazeutische darreichungsform